Many retroviral vectors based on murine leukaemia virus (MLV) contain the first 420 nucleotides of the gag gene, as this was reported to increase vector titre by increasing the efficiency of RNA packaging. In this study, deletion of this gag sequence from its original location did not decrease the titre of two retroviral vectors, pBabe puro and MFG-S The viral components of these vectors comprise transcomplementing genes (gag, pol and env) expressed in packaging cells and the cis-acting sequences (LTRs, primer binding sites and packaging signals) present within the vector. Inclusion of part of the gag gene sequence in vectors was shown to increase recombinant viral titre. 2, 3 This gag sequence was reported to increase the amount of vector packaged into virions and was therefore thought to be an extension of the ⌿ packaging signal.
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The viral components of these vectors comprise transcomplementing genes (gag, pol and env) expressed in packaging cells and the cis-acting sequences (LTRs, primer binding sites and packaging signals) present within the vector. Inclusion of part of the gag gene sequence in vectors was shown to increase recombinant viral titre. 2, 3 This gag sequence was reported to increase the amount of vector packaged into virions and was therefore thought to be an extension of the ⌿ packaging signal. 3, 4 However, retention of the gag sequence in vectors is not desirable as it could aid recombination in the packaging cells, leading to generation of replicationcompetent viruses.
Replication of retroviruses requires export of unspliced genomic RNA from nuclei to cytoplasm. The lentiviruses, such as HIV, encode a trans-acting regulatory protein (Rev), which binds to a cis-acting Rev responsive element (RRE) to facilitate the export of the unspliced genomic RNA. 5, 6 Although the simple retroviruses do not encode a Rev-like protein, a cis-acting element, termed constitutive transport element (CTE), has been identified in MPMV, SRV and RSV. [7] [8] [9] [10] These CTEs are believed to interact with cellular proteins to enhance export of genomic RNA. [11] [12] [13] It has been reported that such CTEs can substitute for RRE/Rev in HIV and SIV vectors. 7, 10, 14, 15 In this study we demonstrate that the first 420 nucleotides of gag sequence in MLV can increase both cytoplasmic RNA level and packaging efficiency of a vector genome. Its substitution by the MPMV CTE results in MLV vectors with an increased titre (up to 10-fold higher).
To analyse the function of the 420 nucleotide gag sequence in MLV vectors, we deleted this from both pBabe puro and MFG-S − as detailed in Figure 1 . The titre of pBabe ⌬gag (1-2 × 10 5 IU/ml) was slightly increased in comparison with the parental vector ( Figure 2a ) and that of MFG ⌬gag (6-8 × 10 5 IU/ml) was the same as the parental vector. These titres were determined on human TE671 cells and are therefore lower than the reported titres for the parental vectors on 3T3 cells. These results do not agree with those of Bender et al 3 and Morgenstern and Land 16 who showed that inclusion of the gag sequence increased vector titre by five-to 10-fold. However, Kim et al 17 have previously reported that removal of the gag sequence from MFG does not decrease vector titre. To examine possible functions of the gag sequence further, we also moved it close to the 3Ј LTRs of the vectors, resulting in pBabe Cgag ( Figure 1a ) and MFG Cgag (Figure 1b) . The titres of these vectors were three-to fourfold higher than the parental vectors ( Figure 2) . Inclusion of the gag sequence in reverse orientation (MFG Cgag R, Figure 1b ) did not increase vector titre (Figure 2b) .
To investigate the mechanism of action of the gag sequence, we performed Northern hybridisation analysis on both cytoplasmic polyadenylated and packaged viral RNA, using a puro fragment as a probe. The deletion of the gag sequence in pBabe puro resulted in a reduction of unspliced genomic RNA accumulated in the cytoplasm (Figure 3a) . However, an increased amount of genomic RNA was packaged (Figure 3b ), in agreement with the increase in titre (Figure 2a ). This suggests that deletion of gag sequence from its original position significantly increases RNA packaging efficiency. Insertion of the gag sequence adjacent to the 3Ј LTR led to a higher level of genomic RNA accumulated in the cytoplasm in comparison with pBabe ⌬gag (Figure 3a ) and a small increase in cytoplasmic genomic RNA for MFG C gag (Figure 4a ). Furthermore, an increased amount of genomic RNA was detected in virus particles ( Figure 3b ) in agreement with the further increase in titre (Figure 2a ). These results demonstrate that transfer of the gag sequence adjacent to the 3Ј LTR augmented vector titre, both by promoting 
a). For MFG derived vectors, the infection efficiency was measured after 48 h infection on a FACScan (Becton Dickinson, Heidelberg, Germany). The percentage of cells expressing EGFP was measured and the viral titre and mean EGFP expression in infected cells was calculated (b).
RNA accumulation in the cytoplasm and also by increasing packaging efficiency of RNA into virus particles.
A 240 nucleotide sequence from MPMV has been shown to promote the nuclear export of unspliced RNA. 7, 8, 11 We therefore examined whether the 240 nucleotide MPMV CTE could enhance MLV titre (Figure 1 ). This sequence shares no homology with the MLV packaging constructs, or human endogenous or infectious retroviruses. It is within the non-coding region of MPMV and its longest potential open reading frame is 24 amino acids. In pBabe puro, the MPMV CTE enhanced vector titre three-to six-fold when substituted in the original gag position (pBabe NCTE, Figure 2a ) or 10-fold when inserted adjacent to the 3Ј LTR (pBabe CCTE, Figure 2a ). In MFG a two-to three-fold enhancement of titre was observed when the MPMV CTE was inserted in either position, and insertion in the reverse orientation did not enhance titre (Figure 2b , MFG NCTE, MFG CCTE and MFG CCTER).
The MPMV CTE has been identified as a cis-acting nuclear export element in MPMV or HIV. 17, 18 We therefore examined whether it increased MLV cytoplasmic RNA. Northern hybridisation analysis showed that insertion of the MPMV CTE, either replacing the gag sequence or adjacent to the 3Ј LTR, promoted the accumulation of unspliced genomic RNA in the cytoplasm. The origin of the RNA species intermediate in size between the genomic and puro RNAs in the CTE constructs is not clear (Figure 3a) ; it is not included in genomic RNA quantification and was not detected in packaged RNA (Figure 3b) . A six-fold increase of RNA was accumulated in the cytoplasm in comparison with pBabe puro, which corresponded to a 15-fold increase in comparison with the parental pBabe ⌬gag (Figure 3a) . Again a modest increase in cytoplasmic genomic RNA was observed when the MPMV CTE was inserted in MFG (Figure 4a ).
Because the CTE promoted accumulation of unspliced genomic RNA in the cytoplasm, it also increased the amount of RNA packaged in virions (Figure 3b , pBabe NCTE) in agreement with the observed increase in titre (Figure 2 ). EGFP expression in cells infected with the MFG-based viruses is shown in Figure 4b . Improved expression compared with parental MFG was detected with the ⌬gag, NCTE and CCTE vectors. The combination of improved titre and EGFP expression makes the MFG-NCTE the most attractive for future use.
In this study, deletion of the MLV gag sequence from the commonly used pBabe and MFG-S − vectors did not decrease viral titres. This finding appears to contradict previous studies in which viral titres or RNA packaging were compared in vectors with or without the gag sequence. 2, 3, 4, 16 However, there is another recent report showing that deletion of the gag sequence from MFG did not affect vector titre. 17 The reason for the discrepancies between results remains unclear. It is possible that use of the newer packaging cell lines [19] [20] [21] which express higher levels of viral proteins, eliminates effects of the gag sequence.
The gag sequence has a modest (2.5-fold) effect on accumulation of vector RNA in the cytoplasm, when included in the pBABE vector. This may partly explain its observed effect on RNA packaging in a previous study, where total cellular RNA and packaged RNA were measured. 3 Significantly, this MLV gag sequence has also been reported to allow rex-independent expression from HTLV-1-based vectors, by enhancing nuclear export. 22 However, deletion of the gag sequence does not eliminate RNA export or viral titre, as is the case for previously characterised retroviral CTEs. 9, 18 If MLV contains a classic CTE, it must lie within sequences which cannot easily be deleted because they contain LTR, primer binding or packaging functions. In our study, the gag sequence can also enhance packaging of cytoplasmic RNA, but only when it is present at the 3Ј end of the vector genome. This demonstrates that it does not have to be part of a continuous packaging signal extending from and that it therefore may not be involved in genome dimerisation and nucleocapsid binding. 23 We have replaced the gag sequence with the MPMV CTE to produce improved versions of the pBabe puro and MFG-S − vectors. The increase in titre obtained by this inclusion of the MPMV CTE suggests that nuclear export of parental vector RNA is suboptimal. Even the modest increase in titre of these new vectors, three-fold in the case of MFG-S − with the MPMV CTE, will extend the potential applications of retroviral vectors, which are Gene Therapy often limited by low titre. In the case of pBabe puro, removal of the gag sequence also allows alignment of the start codon of the transgene with that of gag, which should enhance transgene expression as an internal ribosome entry site facilitates gag translation. 24 The new vectors will also allow elimination of any sequence homology between vectors and packaging constructs, eliminating the risk of recombination in packaging cells. This is particularly valuable for packaging systems which generate retroviral vectors by transient transfection, 21, 25 as multiple copies of vector and packaging constructs are present within a single cell which increases the risk of recombination. It will also be crucial for the preparation of high titre viruses for clinical use. 
